Compare PRPO & NXB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | NXB |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Marine Transportation |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 49.2M |
| IPO Year | 2000 | 2025 |
| Metric | PRPO | NXB |
|---|---|---|
| Price | $26.25 | $2.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 139.2K | 60.9K |
| Earning Date | 05-12-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $24,049,000.00 | ★ $119,866,298.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 29.77 | 21.08 |
| 52 Week Low | $16.14 | $1.79 |
| 52 Week High | $33.63 | $2.57 |
| Indicator | PRPO | NXB |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 47.98 |
| Support Level | $25.46 | $1.79 |
| Resistance Level | $27.59 | $2.35 |
| Average True Range (ATR) | 1.66 | 0.18 |
| MACD | -0.30 | -0.02 |
| Stochastic Oscillator | 35.39 | 32.50 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
NextBoat Inc focused on AI-powered technology platform designed to modernize and scale the world-wide pre-owned marine marketplace.